307 related articles for article (PubMed ID: 23190338)
1. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.
Deshpande A; Pasupuleti V; Thota P; Pant C; Mapara S; Hassan S; Rolston DD; Sferra TJ; Hernandez AV
J Gastroenterol Hepatol; 2013 Feb; 28(2):235-42. PubMed ID: 23190338
[TBL] [Abstract][Full Text] [Related]
2. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
[TBL] [Abstract][Full Text] [Related]
3. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Choi EJ; Lee HJ; Kim KO; Lee SH; Eun JR; Jang BI; Kim TN
Scand J Gastroenterol; 2011 May; 46(5):616-20. PubMed ID: 21275825
[TBL] [Abstract][Full Text] [Related]
4. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
5. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis.
Kwon JH; Koh SJ; Kim W; Jung YJ; Kim JW; Kim BG; Lee KL; Im JP; Kim YJ; Kim JS; Yoon JH; Lee HS; Jung HC
J Gastroenterol Hepatol; 2014 Apr; 29(4):775-81. PubMed ID: 24219827
[TBL] [Abstract][Full Text] [Related]
6. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis.
Huang KW; Kuan YC; Luo JC; Lin CL; Liang JA; Kao CH
Eur J Intern Med; 2016 Jul; 32():91-5. PubMed ID: 27139916
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
Terg R; Casciato P; Garbe C; Cartier M; Stieben T; Mendizabal M; Niveyro C; Benavides J; Marino M; Colombato L; Berbara D; Silva M; Salgado P; Barreyro F; Fassio E; Gadano A;
J Hepatol; 2015 May; 62(5):1056-60. PubMed ID: 25481567
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
[TBL] [Abstract][Full Text] [Related]
9. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
de Vos M; De Vroey B; Garcia BG; Roy C; Kidd F; Henrion J; Deltenre P
Liver Int; 2013 Oct; 33(9):1316-23. PubMed ID: 23730823
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis.
Yu T; Tang Y; Jiang L; Zheng Y; Xiong W; Lin L
Dig Liver Dis; 2016 Apr; 48(4):353-9. PubMed ID: 26795544
[TBL] [Abstract][Full Text] [Related]
11. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis.
Xu HB; Wang HD; Li CH; Ye S; Dong MS; Xia QJ; Zhang AQ; Pan K; Ge XL; Dong JH
Genet Mol Res; 2015 Jul; 14(3):7490-501. PubMed ID: 26214428
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
Kim JH; Lim KS; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Koh KC; Paik SW
J Gastroenterol Hepatol; 2017 May; 32(5):1064-1070. PubMed ID: 28449345
[TBL] [Abstract][Full Text] [Related]
14. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
van Vlerken LG; Huisman EJ; van Hoek B; Renooij W; de Rooij FW; Siersema PD; van Erpecum KJ
Eur J Clin Invest; 2012 Jul; 42(7):760-7. PubMed ID: 22288900
[TBL] [Abstract][Full Text] [Related]
15. Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - a systematic review and meta-analysis.
Trikudanathan G; Israel J; Cappa J; O'Sullivan DM
Int J Clin Pract; 2011 Jun; 65(6):674-8. PubMed ID: 21564440
[TBL] [Abstract][Full Text] [Related]
16. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors: bacterial pneumonia.
Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
[TBL] [Abstract][Full Text] [Related]
18. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Ratelle M; Perreault S; Villeneuve JP; Tremblay L
Can J Gastroenterol Hepatol; 2014 Jun; 28(6):330-4. PubMed ID: 24945188
[TBL] [Abstract][Full Text] [Related]
19. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis.
Deschênes M; Villeneuve JP
Am J Gastroenterol; 1999 Aug; 94(8):2193-7. PubMed ID: 10445549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
